Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

757
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
757
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

561
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
561

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

TM-Loop: Transformer multi-omics hierarchical detection of chromatin loop.

Scientific reports·2026
Same author

A method for structural variant detection using Hi-C contact matrix and neural networks.

Scientific reports·2026
Same author

Pregnancy phytochemical dietary index is associated with the risk of gestational diabetes and perinatal outcomes.

Endocrine connections·2025
Same author

MEGDTA: multi-modal drug-target affinity prediction based on protein three-dimensional structure and ensemble graph neural network.

BMC genomics·2025
Same author

HiSVision: A Method for Detecting Large-Scale Structural Variations Based on Hi-C Data and Detection Transformer.

Interdisciplinary sciences, computational life sciences·2024
Same author

The effect of probiotics on gestational diabetes mellitus: an umbrella meta-analysis.

BMC endocrine disorders·2024

相关实验视频

Updated: Jul 15, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K

DGDTA:动态图表注意力网络用于预测药物标结合亲和力.

Haixia Zhai1, Hongli Hou1, Junwei Luo2

  • 1School of Software, Henan Polytechnic University, Jiaozuo, 454003, China.

BMC bioinformatics
|September 30, 2023
PubMed
概括

本研究介绍了动态图DTA (DGDTA),这是一种用于预测药物标结合亲和力 (DTA) 的深度学习模型. 通过分析药物结构和蛋白质序列,DGDTA提高了准确性,优于现有的方法.

关键词:
药物发现 药物发现药物目标结合亲缘关系动态图表注意力网络的动态图.长期短期记忆 长期短期记忆

更多相关视频

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

241
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

相关实验视频

Last Updated: Jul 15, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.6K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

241
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.9K

科学领域:

  • 计算化学是一种计算化学.
  • 生物信息学是一种生物信息学.
  • 机器学习在药物发现中的作用

背景情况:

  • 准确的药物标结合亲和力 (DTA) 对于药物发现和重新定位至关重要.
  • 现有的DTA预测方法需要进一步分析蛋白质和药物特征.
  • 深度学习为改善DTA预测提供了一个有希望的途径.

研究的目的:

  • 开发一种新的深度学习模型,用于准确的药物标结合亲和力预测.
  • 加强对药物和蛋白质特征的分析,用于DTA预测.
  • 改进计算机药物发现领域的现有方法.

主要方法:

  • 拟议的动态图形DTA (DGDTA) 模型使用动态图形注意网络和双向长期短期记忆 (Bi-LSTM) 网络.
  • 输入包括通过简化分子输入线输入系统 (SMILES) 和蛋白质氨基酸序列表示的药物化合物.
  • 药物以图形形式建模,动态注意力得分突出重要原子和边缘;Bi-LSTM提取上下文蛋白质序列特征.

主要成果:

  • 通过整合药物和蛋白质特征向量,DGDTA通过一个完全连接的层有效地预测DTA.
  • 该模型利用药物特征提取的动态注意力和蛋白质序列分析的Bi-LSTM.
  • 源代码在GitHub上公开提供.

结论:

  • 与现有的方法相比,DGDTA在预测药物标结合亲和度方面表现出更高的准确性.
  • 建议的深度学习方法提供了一种更有效的方法来预测DTA.
  • 这一进步有助于更高效的药物发现和重新定位策略.